Skip to main content
SpringerLink
Log in

The Place of High-Dose Inhaled Corticosteroids in Asthma Therapy

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Adelroth E, Rosenhall L, Glennow C. High-dose inhaled budesonide in the treatment of severe steroid-dependent asthmatics. Allergy 40: 58–64, 1985

    Article  PubMed  CAS  Google Scholar 

  • Bjorkander J, Formgren H, Johannson SA, Millqvist E. Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma. European Journal of Respiratory Diseases 63(Suppl. 122): 108–117, 1982

    Google Scholar 

  • Boyd G, Abdallah S, Clark R. Twice or four times daily beclomethasone dipropionate in mild asthma? Clinical Allergy 15: 383–389, 1985

    Article  PubMed  CAS  Google Scholar 

  • Brattsand R, Thalen A, Roempke K, Kallstrom L, Gruvstad E. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. European Journal of Respiratory Diseases 63(Suppl. 122): 62–73, 1982

    Google Scholar 

  • Choo-Kang YFJ, Cooper EJ, Tribe AE, Grant IWB. Beclomethasone dipropionate by inhalation in the treatment of airways obstruction. British Journal of Diseases of the Chest 66: 101–106, 1972

    Article  PubMed  CAS  Google Scholar 

  • Clark TJH. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet 1: 1361–1364, 1972

    Article  PubMed  CAS  Google Scholar 

  • Costello JF, Clark TJH. Response of patients receiving high-dose beclomethasone dipropionate. Thorax 29: 571–573, 1974

    Article  PubMed  CAS  Google Scholar 

  • Francis RS. High-dose beclomethasone aerosol for severe asthma. Abstract. British Journal of Diseases of the Chest 73: 424, 1979

    Google Scholar 

  • Francis RS. Adrenocortical function during high-dose beclomethasone aerosol therapy. Clinical Allergy 14: 49–53, 1984

    Article  PubMed  CAS  Google Scholar 

  • Gaddie J, Reid IW, Skinner C, Petrie GR, Sinclair DJM, et al. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet 2: 280–281, 1973

    Article  PubMed  CAS  Google Scholar 

  • Harris DM, Martin LE, Harrison C, Jack D. The effect of oral and inhaled beclomethasone dipropionate on adrenal function. Clinical Allergy 3: 243–248, 1973

    Article  PubMed  CAS  Google Scholar 

  • Hodson ME, Batten JC, Clarke SW, Gregg I. Beclomethasone dipropionate aerosol in asthma. American Review of Respiratory Diseases 110: 403–408, 1974

    CAS  Google Scholar 

  • Johansson SA, Andersson K, Brattsand R, Gruvstad E, Hedner P. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. European Journal of Respiratory Diseases 22: 523–529, 1982

    CAS  Google Scholar 

  • Laursen LC, Taudorf E, Weeke B. High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. European Journal of Respiratory Diseases 68: 19–28, 1986

    PubMed  CAS  Google Scholar 

  • McGivern DV, Ward M, Macfarlane JT, Roderick-Smith WH. Failure of once daily inhaled corticosteroid treatment to control chronic asthma. Thorax 39: 933–934, 1984

    Article  PubMed  CAS  Google Scholar 

  • Mecoy RJ, Laby B. Beclomethasone dipropionate in twice daily treatment of asthma. Australian Family Physician 9: 721–727, 1980

    PubMed  CAS  Google Scholar 

  • Medical Research Council Collaborative Trial. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet 2: 303–307, 1974

    Google Scholar 

  • Munch EP, Laursen LC, Dirksen A, Weeke ER, Weeke B. Dose frequency in the treatment of asthmatics with inhaled topical steroids. European Journal of Respiratory Diseases 67: 254–260, 1985

    PubMed  CAS  Google Scholar 

  • Munch EP, Taudorf E, Weeke B. Dose frequency in the treatment of asthmatics with inhaled topical steroid. European Journal of Respiratory Diseases 63(Suppl. 122): 143–153, 1982

    Google Scholar 

  • Mygind N. Mucosal changes in the airways during long term corticosteroid treatment. European Journal of Respiratory Diseases 63(Suppl. 122): 229–234, 1982

    Google Scholar 

  • Newman SP, Moren F, Pavia D, Little F, Clarke SW. Deposition of pressurised suspension aerosols inhaled through extension devices. American Review of Respiratory Diseases 124: 317–320, 1981

    CAS  Google Scholar 

  • Rafferty P, Tucker LG, Frame MH, Ferguson RJ, Biggs B-A, et al. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects. British Journal of Diseases of the Chest 79: 244–250, 1985

    Article  PubMed  CAS  Google Scholar 

  • Smith MJ, Hodson ME. High-dose beclomethasone inhaler in the treatment of asthma. Lancet 1: 265–269, 1983a

    Article  PubMed  CAS  Google Scholar 

  • Smith MJ, Hodson ME. Effects of long term inhaled high-dose beclomethasone dipropionate on adrenal function. Thorax 38: 676–681, 1983b

    Article  PubMed  CAS  Google Scholar 

  • Smith MJ, Hodson ME. Twice daily beclomethasone dipropionate administered with a concentrated aerosol inhaler: efficacy and patient compliance. Thorax 41: 960–963, 1986

    Article  PubMed  CAS  Google Scholar 

  • Spitzer SA, Kaufman H, Koplovitz A, Topilsky M, Blum I. Beclomethasone dipropionate and chronic asthma. Chest 70: 33–42, 1976

    Article  Google Scholar 

  • Stiksa G, Nemcek K, Glennow C. Adrenal function in asthmatics treated with high-dose budesonide. Respiration 48: 91–93, 1985

    Article  PubMed  CAS  Google Scholar 

  • Toogood JH. Concentrated aerosol formulations in asthma. Lancet 2: 790–791, 1983

    Article  PubMed  CAS  Google Scholar 

  • Toogood JH, Jennings B, Baskerville J, Johansson SA. Clinical use of spacer systems for corticosteroid inhalation therapy: a preliminary analysis. European Journal of Respiratory Diseases 63(Suppl. 122): 100–107, 1982

    Google Scholar 

  • Toogood JH, Jennings BA, Greenway RW, Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. Journal of Allergy and Clinical Immunology 65: 145–153, 1980

    Article  PubMed  CAS  Google Scholar 

  • Toogood JH, Lefcoe NM, Haines DSM, Jennings B, Errington N, et al. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. Journal of Allergy and Clinical Immunology 59: 298–308, 1977

    Article  PubMed  CAS  Google Scholar 

  • Willey RF, Godden DJ, Carmichael J, Preston P, Frame MH, et al. Twice daily inhalation of a new corticosteroid budesonide, in the treatment of chronic asthma. European Journal of Respiratory Diseases 63: 138–142, 1982

    Google Scholar 

  • Williams AJ, Baghat MS, Stableforth DE, Cayton RM, Shenoi PM, et al. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 38: 813–821, 1983

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Medicine, Brompton Hospital, Fulham Road, London, SW3 6HP, England

    Michael J. Smith

Authors
  1. Michael J. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, M.J. The Place of High-Dose Inhaled Corticosteroids in Asthma Therapy. Drugs 33, 423–429 (1987). https://doi.org/10.2165/00003495-198733050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198733050-00001

Keywords

Search

Navigation